GLP-1 Pills: Every Oral GLP-1 Medication Ranked (2026)
Three GLP-1 pills are FDA-approved in 2026 and a growing list of compounded oral forms are sold online. This guide ranks all of them on trial results, price and fasting rules, with the compounded prices re-read on each provider's site by our daily price check.
Quick Answer: Which GLP-1 Pills Exist and What Do They Cost?
There are three FDA-approved GLP-1 pills in 2026: the Wegovy pill (oral semaglutide, $149–$299/month self-pay by dose, 13.6% average weight loss in OASIS 4), Foundayo (orforglipron, $149–$299/month by dose via LillyDirect, up to 12.4% in ATTAIN-1, no food or water restrictions) and Rybelsus (oral semaglutide for type 2 diabetes, $936 list). Compounded oral semaglutide, sold as lozenges, drops, sublingual and dissolving tablets, runs $129–$299/month from the tracked telehealth providers we price, with the visit included, but it is not FDA-approved and has no published trial.
Every GLP-1 Pill Available in 2026, Ranked
Ranked on published trial results first and self-pay price second: the Wegovy pill and Foundayo lead because they are the only pills approved for weight loss with a pivotal trial behind them; Rybelsus follows as the diabetes option; the 5 compounded oral products from tracked providers are ordered by verified price, from $129/month.
| # | Pill | Status | Self-pay / mo | Evidence | Fasting rule | Link |
|---|---|---|---|---|---|---|
| 1 | Wegovy pill oral semaglutide, 1.5 → 25 mg daily | FDA-approved for weight management, December 22, 2025 | $149–$299 | 13.6% at 64 wk (OASIS 4; 16.6% adherent) | Empty stomach, 30-min wait | Wegovy prices |
| 2 | Foundayo orforglipron, up to 17.2 mg daily | FDA-approved for weight management, April 1, 2026 | $149 | up to 12.4% at 72 wk (ATTAIN-1) | None | Foundayo guide |
| 3 | Rybelsus oral semaglutide, 3 / 7 / 14 mg daily | FDA-approved for type 2 diabetes (2019); off-label for weight | $936 list | 3–5% weight loss at 14 mg (PIONEER) | Empty stomach, 30-min wait | Rybelsus prices |
| 4 | Strut HealthDaily oral lozenge (semaglutide)FDA letter 2026 | Compounded, not FDA-approved | from $129 | No published trial of the oral form | Per product label | Visit Strut Health |
| 5 | ShedRxGLP-1 lozenges (semaglutide); drops $229, tablets $299 | Compounded, not FDA-approved | from $199 | No published trial of the oral form | Per product label | Visit ShedRx |
| 6 | MEDViDissolvable GLP-1 tablets (semaglutide)FDA letter 2026 | Compounded, not FDA-approved | from $249 | No published trial of the oral form | Per product label | Visit MEDVi |
| 7 | Direct Meds GLP-1Sublingual semaglutideFDA letter 2025 | Compounded, not FDA-approved | from $249 | No published trial of the oral form | Per product label | Visit Direct Meds |
| 8 | MangoRx“Slim” orally dissolving tablet (semaglutide + B6) | Compounded, not FDA-approved | from $299 | No published trial of the oral form | Per product label | Visit MangoRx |
Brand prices are NovoCare and LillyDirect self-pay; compounded prices are each provider's advertised standing rate, re-read by our daily price check (GLP-1 Price Index snapshot September 21, 2026). Not ranked: SkinnyRx sublingual tablets shown only at a “$149 / $199 first month” promo with no renewal price; Wellorithm lists oral semaglutide but publishes no price; DudeMeds lists oral semaglutide but publishes no separate price. Brand-pill platforms: Sesame Care sells the Wegovy pill at $149 plus a $59/month care subscription (about $208/month all-in); Hers, Hims and Ro add a $74–$149/month membership to the same $149 pill price.
Best GLP-1 Pill by Situation
Which GLP-1 pill gives the most weight loss?
The Wegovy pill at its 25 mg maintenance dose: 13.6% average loss over 64 weeks in OASIS 4 (16.6% among people who stayed on treatment), close to the 14.9% of the weekly injection in STEP 1. It costs $299/month at that dose.
Which GLP-1 pill is easiest to take?
Foundayo: a once-daily tablet with no food or water restrictions, at $149–$299/month by dose cash through LillyDirect. Every semaglutide pill, approved or compounded, has to be taken on an empty stomach with a 30-minute wait.
What is the cheapest GLP-1 pill?
Among FDA-approved pills, the Wegovy pill and Foundayo tie at $149/month self-pay for the starting doses. Among compounded oral forms, Strut Health at $129/month is the lowest verified price we track, visit and shipping included; the injectable floor is $69/month.
Which GLP-1 pill is for type 2 diabetes?
Rybelsus (3, 7 or 14 mg) is the only pill approved for type 2 diabetes, listing at $936/month before insurance, which usually covers it. Expect modest weight loss of about 3–5%; it is a glucose drug first.
The Wegovy Pill (Oral Semaglutide)
The Wegovy pill is oral semaglutide, approved by the FDA on December 22, 2025 for chronic weight management and launched in January 2026 at $149/month self-pay for its 1.5 mg starting dose. It carries semaglutide through the stomach lining with Novo Nordisk's SNAC absorption enhancer, which is why it must be taken on waking, on an empty stomach, with no more than four ounces of water, followed by a 30-minute wait. The dose steps up from 1.5 mg to 4 mg, 9 mg and the 25 mg maintenance dose over several months.
Wegovy pill self-pay price by dose
NovoCare self-pay prices, read September 2026. Commercially insured patients may pay about $25/month with the savings card; Medicare's GLP-1 Bridge prices Wegovy at $50/month for eligible beneficiaries.
In OASIS 4 (NEJM, 2025; figures as quoted in the FDA approval announcement) the 25 mg dose produced 13.6% average body-weight loss over 64 weeks regardless of adherence and 16.6% among participants who stayed on treatment, against 14.9% over 68 weeks for the 2.4 mg weekly injection in STEP 1 (NEJM, 2021). The two have never been compared head to head. Full pricing paths are on our Wegovy cost page and the pill-versus-pen trade-offs on Wegovy pill vs injection.
Foundayo (Orforglipron)
Foundayo is Eli Lilly's orforglipron, the first oral small-molecule GLP-1, approved by the FDA on April 1, 2026 for weight management and sold for $149–$299/month by dose cash through LillyDirect. Because it is not a peptide it needs no absorption enhancer, so it is taken once daily with or without food or water, the single biggest practical difference from the semaglutide pills.
- Results: in the ATTAIN-1 phase 3 trial the top 17.2 mg dose produced 12.4% average weight loss over 72 weeks versus 0.9% on placebo, a little below the Wegovy pill's 13.6% at 64 weeks.
- Diabetes: ATTAIN-2 showed an average 1.8-point A1C reduction in type 2 diabetes, but the approval is for weight management only.
- Switching: ATTAIN-MAINTAIN studied patients moving from injectable semaglutide or tirzepatide to orforglipron to maintain their weight loss.
- Price: $149/month cash at LillyDirect; telehealth platforms that prescribe it (ShedRx, Hers, Hims) add their own membership or provider fee on top.
Read the full Foundayo guide and the Foundayo cost breakdown.
Rybelsus
Rybelsus is oral semaglutide at 3, 7 and 14 mg, FDA-approved for type 2 diabetes since 2019 and listed at $936/month before insurance. It uses the same SNAC tablet technology as the Wegovy pill at lower doses tuned for blood sugar, so weight loss is modest, about 3–5% at 14 mg in the PIONEER programme, and it carries the same empty-stomach rule. Prescribing it for weight loss is off-label and rarely covered; if weight is the goal, the Wegovy pill is the same molecule at a weight-loss dose for a fraction of the list price. Details on our Rybelsus cost page.
Compounded Oral and Sublingual Semaglutide
Compounded oral semaglutide is sold by telehealth providers as lozenges, liquid drops, sublingual tablets and orally dissolving tablets at $129–$299/month among the tracked providers we price, with the prescriber visit included and no insurance involved. These are prepared by 503A compounding pharmacies from a prescription; none is an FDA-approved finished product, none uses Novo Nordisk's SNAC technology, and no controlled trial has measured how much semaglutide a sublingual or lozenge form actually absorbs. What you are buying is the needle-free route and the price, on the strength of the pharmacy behind the provider.
- Strut Health — Daily oral lozenge (semaglutide), from $129/month. Same price as Strut's injection; free visits and shipping. (Strut Health review)
- ShedRx — GLP-1 lozenges (semaglutide); drops $229, tablets $299, from $199/month. Five delivery forms; 2-month minimum; conditional 120-day guarantee. (ShedRx review)
- MEDVi — Dissolvable GLP-1 tablets (semaglutide), from $249/month. “Starting at $249”; injections start at $179 first month, $299 refills. (MEDVi review)
- Direct Meds GLP-1 — Sublingual semaglutide, from $249/month. All-inclusive; FDA marketing-claims letter Sept 2025 (see review). (Direct Meds GLP-1 review)
- MangoRx — “Slim” orally dissolving tablet (semaglutide + B6), from $299/month. Oral-only provider; month-to-month, price locked. (MangoRx review)
3 tracked providers also list oral semaglutide without a verifiable standing price (SkinnyRx, Wellorithm, DudeMeds), so they are not ranked. Only Strut Health at $129/month undercuts the $149 approved-pill floor; the other compounded forms cost $199–$299/month, more than the Wegovy pill or Foundayo at their starting doses, so their case is needle-free convenience, not price. If you want trial-backed dosing, the Wegovy pill or Foundayo at $149/month is the honest comparison, and our cheapest semaglutide ranking covers the injectable route from $69/month.
GLP-1 Pills vs Injections
Injections still win on absorption, dosing frequency and peak weight loss; pills win on convenience, travel and, for the approved brands, price: the Wegovy pill and Foundayo cost $149–$299/month against $349/month for the self-pay Wegovy pen and $1,349 at list.
| Factor | GLP-1 pills | GLP-1 injections | Winner |
|---|---|---|---|
| Convenience | Daily tablet, no needles, no cold chain | Weekly pen, refrigeration, sharps disposal | Oral |
| Absorption | About 1% bioavailability for oral semaglutide (SNAC-dependent); orforglipron absorbs without an enhancer | Near-complete, consistent drug levels | Injectable |
| Weight loss in trials | 13.6% (Wegovy pill, OASIS 4, 64 wk); 12.4% (Foundayo, ATTAIN-1, 72 wk) | 14.9% (semaglutide, STEP 1); about 21% (tirzepatide, SURMOUNT-1) | Injectable (slightly) |
| Self-pay cost, brand | $149–$299/mo (Wegovy pill by dose); $149–$299/mo (Foundayo) | $349/mo Wegovy pen self-pay ($199 intro for two fills); $1,349 list | Oral |
| Self-pay cost, compounded | $129–$299/mo, no trial data | from $69/mo semaglutide, $119/mo tirzepatide | Injectable |
| Dosing frequency | Once daily | Once weekly | Injectable |
| Food restrictions | Semaglutide pills: empty stomach, 30-min wait; Foundayo: none | None | Injectable |
| Side effects | Same GI profile; nausea can be more noticeable during titration | Standard GI effects (nausea, constipation) | Tie |
| Travel | No cold chain, no needles through security | Cold storage, needle declaration | Oral |
Trial figures are the published averages at the stated durations; none of these products has been compared head to head. Updated September 2026.
Who Should Consider a GLP-1 Pill
- Needle-averse patients who would otherwise delay or skip treatment
- Frequent travelers who find cold-chain storage and sharps disposal impractical
- Cash payers who want an FDA-approved product at $149/month rather than a compounded one
- People who cannot manage an empty-stomach routine and therefore suit Foundayo specifically
- Patients with dexterity problems that make self-injection difficult
- People who struggle with daily adherence; a weekly injection is easier to keep up
- Those with gastroparesis or severe GI conditions that affect absorption
- Anyone chasing maximum weight loss, where tirzepatide injections lead by several points
- Patients on morning medications that must be taken with food (semaglutide pills)
- People who want trial-backed dosing but are considering a compounded sublingual, which has none
Limitations of GLP-1 Pills
GLP-1 pills are a real advance, and they come with trade-offs that decide whether a tablet or a pen suits you.
Empty-stomach rule (semaglutide pills)
The Wegovy pill and Rybelsus must be taken first thing on waking with no more than four ounces of plain water, followed by at least 30 minutes without food, drink or other medication. Food in the stomach cuts absorption sharply. Foundayo has no such rule.
Low, variable bioavailability
Only about 1% of oral semaglutide reaches the bloodstream, which is why oral doses are measured in milligrams and injectable doses in fractions of a milligram. Stomach pH, motility and hydration change how much is absorbed from day to day.
Dose-dependent pricing
The Wegovy pill's $149 price covers only the 1.5 mg starting dose; 4 mg is $199 and both the 9 mg and 25 mg doses are $299/month (NovoCare self-pay, read September 21, 2026). Budget for the maintenance figure, not the headline. Foundayo is a flat $149.
Daily compliance
A daily pill plus a fasting window is more to remember than a weekly pen. Missed or mistimed doses lower drug levels, and adherence is exactly what separated OASIS 4's 13.6% from its 16.6% result.
No trial data for compounded oral forms
Lozenges, drops and sublingual tablets from compounding pharmacies have never been tested in a controlled trial and do not use the SNAC enhancer, so their real absorbed dose is unknown.
GI side effects during titration
Nausea and stomach discomfort can be more pronounced with oral semaglutide during dose escalation, because the tablet dissolves against the stomach lining.
GLP-1 Pills: Frequently Asked Questions
What are the best GLP-1 pills for weight loss in 2026?
The best GLP-1 pills for weight loss are the two FDA-approved for it: the Wegovy pill (oral semaglutide, 25 mg maintenance dose, 13.6% average weight loss over 64 weeks in OASIS 4, 16.6% with full adherence) and Foundayo (orforglipron, up to 12.4% at the top 17.2 mg dose over 72 weeks in ATTAIN-1, taken with no food or water restrictions). Both cost $149/month self-pay at their starting doses; the Wegovy pill rises to $299 at 25 mg. Rybelsus is approved only for type 2 diabetes and produces about 3–5% weight loss. Compounded oral semaglutide is cheaper (from $129/month) but is not FDA-approved and has no published trial.
Which GLP-1 pill has the best reviews and results?
On trial results the Wegovy pill leads: 13.6% average weight loss at 64 weeks (OASIS 4, NEJM 2025) against Foundayo's 12.4% at 72 weeks (ATTAIN-1) and Rybelsus's 3–5% at 14 mg. On convenience Foundayo leads, because it is the only GLP-1 pill with no empty-stomach rule; the Wegovy pill and Rybelsus must be taken on waking with a sip of water and a 30-minute wait before food. GLP-1 pill reviews from telehealth patients mostly rate the provider experience, not the molecule, so we compare pills on trial data and price and review providers separately.
Are there cheap GLP-1 pills?
Yes. The cheapest FDA-approved GLP-1 pills are the Wegovy pill and Foundayo at $149/month self-pay for the starting doses, roughly 85% below the $936 list price of Rybelsus. Compounded oral forms of semaglutide from tracked telehealth providers run $129–$299/month with the visit and shipping included (Strut Health $129, ShedRx $199, MEDVi $249); only Strut Health undercuts the approved pills, and none is FDA-approved. Brand-only platforms such as Hers, Hims and Ro add a $74–$149/month membership on top of the $149 pill price.
Is sublingual semaglutide as effective as injections?
There is no published trial of sublingual semaglutide, so nobody can say. Semaglutide's weight-loss evidence comes from the weekly injection (14.9% over 68 weeks in STEP 1, NEJM 2021) and from the FDA-approved oral tablet, which uses Novo Nordisk's SNAC absorption enhancer to get about 1% of the dose into the bloodstream (13.6% in OASIS 4). Compounded sublingual drops, lozenges and dissolving tablets are prepared by 503A pharmacies without that technology, and how much semaglutide they absorb has not been measured in a controlled trial. They cost $129–$299/month from tracked providers, so apart from Strut Health they are not cheaper than the $149 approved pills, and you are trusting the pharmacy, not trial data.
Is the Wegovy pill as effective as the injection?
Nearly. Oral semaglutide at the 25 mg maintenance dose produced 13.6% average weight loss over 64 weeks in OASIS 4 (16.6% among people who stayed on treatment), compared with 14.9% over 68 weeks for the 2.4 mg weekly injection in STEP 1. There is no head-to-head trial, and the pill requires an empty stomach and a 30-minute wait before eating, which the injection does not.
Is Foundayo (orforglipron) available now?
Yes. The FDA approved Foundayo on April 1, 2026 for chronic weight management in adults with obesity, or overweight with a weight-related condition, and LillyDirect sells it from $149/month cash at the starting doses, $199 at 5.5 mg and $299/month from 9 mg up — the same ladder as the Wegovy pill. It is the first oral small-molecule GLP-1: a once-daily tablet taken with or without food, which is its main practical advantage over the Wegovy pill. In ATTAIN-1 the top 17.2 mg dose produced 12.4% average weight loss over 72 weeks versus 0.9% on placebo.
Can I switch from an injectable GLP-1 to a pill?
Yes, with your prescriber's guidance. Switching from injectable semaglutide to the Wegovy pill means re-titrating through the oral doses (1.5, 4, 9 and 25 mg), and Lilly's ATTAIN-MAINTAIN trial studied patients moving from injectable semaglutide or tirzepatide to orforglipron to hold their weight loss. Do not switch on your own: changing the route changes blood levels and side effects, and compounded oral products have no dose-equivalence data at all.
What happens if I eat before taking oral semaglutide?
Food in the stomach sharply reduces absorption of oral semaglutide, because the SNAC-assisted tablet has to dissolve against the stomach lining. Take the Wegovy pill or Rybelsus on waking with up to 4 ounces of plain water and wait at least 30 minutes before eating, drinking or taking other medication. Foundayo does not have this restriction.
Are GLP-1 pills covered by insurance?
Coverage is expanding but uneven. Many commercial plans now cover the Wegovy pill for weight management when BMI criteria are met, and Novo Nordisk's savings card can bring commercially insured copays to about $25/month; Rybelsus is widely covered for type 2 diabetes. Medicare's GLP-1 Bridge has priced Wegovy at $50/month for eligible beneficiaries since July 2026. Foundayo coverage depends on the plan; its $149 cash price is the fallback. Compounded oral semaglutide is never covered.
Are there GLP-1 pills for type 2 diabetes?
Yes. Rybelsus (oral semaglutide 3, 7 and 14 mg) has been FDA-approved for type 2 diabetes since 2019, lists at $936/month before insurance, and produces modest weight loss of about 3–5%. Foundayo's ATTAIN-2 trial showed an average 1.8-point A1C reduction in people with type 2 diabetes, but its approval is for weight management; a diabetes indication would need a separate FDA decision.
Compare Every Verified GLP-1 Program
Pills and injections, brand and compounded, ranked by verified price. Our #1 pick Embody starts at $69/month.